Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-198X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome ; day:18 ; month:12 ; year:2018 ; pages:1-9
Pediatric nephrology ; (18.12.2018), 1-9
- Creator
-
Maxted, Andrew P.
Dalrymple, Rebecca A.
Chisholm, Denise
McColl, John
Tse, Yincent
Christian, Martin T.
Reynolds, Ben C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00467-018-4172-3
- URN
-
urn:nbn:de:101:1-2019020620575144107224
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maxted, Andrew P.
- Dalrymple, Rebecca A.
- Chisholm, Denise
- McColl, John
- Tse, Yincent
- Christian, Martin T.
- Reynolds, Ben C.
- SpringerLink (Online service)
Other Objects (12)
Rituximab for nephrotic syndrome in children
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse
Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Correction: Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital
Rituximab for nephrotic syndrome in children
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse
Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Correction: Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital
Rituximab for nephrotic syndrome in children
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse
Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Correction: Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies